Navigation Links
Collaborative Drug Discovery 2nd Annual Community Meeting - Oct. 7, 2008, Speakers Confirmed & Call for Posters
Date:7/31/2008

BURLINGAME, Calif., July 31 /PRNewswire/ -- Collaborative Drug Discovery invites you to submit your poster presentation and register at http://www.acteva.com/go/cdd to attend the 2nd Annual CDD Community Meeting (a free, 1-day event) on October 7th. The CDD Community Meeting is the best place for the CDD community and all scientists to get together, discuss their research projects, and showcase their work to others in the community.

Early List of Confirmed Speakers:

-- David Sullivan, MD, Johns Hopkins

-- Fred Buckner MD, University of Washington

-- Janice Kranz, PhD, Stanley Center for Psychiatric Research, Broad

Institute of MIT & Harvard

-- Conor Caffrey, PhD, Sandler Center, UCSF

-- Jean Claude-Bradley, PhD Dept. of Chemistry, Drexel University

-- Sean Ekins, PhD, ex-Pfizer/Lilly Computational Chemist

-- Andrea Altieri, PhD, ASINEX

-- Robert Damoiseaux, PhD, UCLA Molecular Screening Shared Resource (MSSR)

Center

-- Moses Hohman, PhD, Head of Software, Collaborative Drug Discovery (CDD

roadmap)

-- J. Leighton Read, MD (Alloy Ventures) -- Financing Biomedical

Innovation from academia to the market: From FluMist(TM) to Priority

Review Vouchers and other stories

-- Russell "Rusty" Bromley, Chief Operating Officer, Myelin Repair

Foundation

Timely panel topics:

-- Panel #1: What Foundations are looking for from Academic researchers?

-- Panel #2: What makes collaborations successful within and between

groups?

Who should attend?

-- Scientists working in drug discovery

-- Researchers who are involved in collaborations or generate complex drug

discovery data

-- Students who want to learn more about the drug discovery industry

-- People who wish to network, establish new or strengthen existing

collabo
'/>"/>

SOURCE Collaborative Drug Discovery, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Malaria Vaccine Developer Sanaria Inc. and the University of Maryland Biotechnology Institute Awarded Collaborative, Multi-Year, US $600,000 NIH Phase I Small Business Innovation Research Grant
2. Medpedia Announced, Worlds Largest Collaborative Online Encyclopedia of Medicine and Health
3. Access Granted to Present at the Collaborative Communications Summit: Health Technology Investment Forum
4. Patient Centered Primary Care Collaborative Statement on Passage of Medicare Bill
5. Collaborative Launches Initiative to Protect Rights of Parents with Mental Illnesses
6. American Red Cross and NSF Scrub Club(R) Announce Collaborative Agreement
7. DFG establishes 8 new Collaborative Research Centers
8. Collaborative Drug Discovery and Myelin Repair Foundation Announce Partnership
9. Perrigo Company Announces Collaborative Agreement for Generic Topical Products With Pentech
10. The Leukemia & Lymphoma Society and MannKind Corporation Announce Collaborative Research Agreement
11. Rural Maryland Hospitals Form Unprecedented Collaborative to Improve Patient Care

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... A majority of Americans support a ...but most lack confidence that the cost, quality, v... in the next year, according to a survey released ...urvey respondents said they believe a public optio...gislation. Only about one in five, however, believ...
(Date:12/2/2009)...3 Van Andel Research Institute (VA...plant hormone abscisic acid (ABA) works at the mol...al stresses such as drought and cold. Their findi... engineer crops that thrive in harsh environments ... The findings could also have implications for st...
(Date:12/2/2009)...ewswire/ -- Reportlinker.com announces that a new ...ue: ,, Sterilization Technologies: The U.S. M...0/Sterilization-Technologies-The-US-Market.html ,...quipment to the sterilization industry in 2008, an...te for 2009-2014. ,, Explains how the trends of...
(Date:12/2/2009)...Newswire/ -- Reportlinker.com announces that a new...gue: ,, Kinase Inhibitors: Global Markets ,...-Inhibitors-Global-Markets.html ,, Forecasts...rs 2005 through 2008, and projections for the mark...h 2014 ,, An overview of the market for the ki...
(Date:12/2/2009)...swire-USNewswire/ -- In response to a press confe... ," an initiative from the U.S. Anti-Doping Agen...r Responsible Nutrition (CRN), the leading trade a...ustry, issued the following statement: ,, Sta..., "We share the concerns of Travis Tygart (USAD...
Breaking Medicine News(10 mins):Health News:Thomson Reuters Survey: Most Americans Support Public Option in Healthcare Reform Legislation but Are Skeptical Healthcare Will Improve in 2010 2Health News:VAI Researchers Find Long Awaited Key to Creating Drought Resistant Crops 2Health News:VAI Researchers Find Long Awaited Key to Creating Drought Resistant Crops 3Health News:VAI Researchers Find Long Awaited Key to Creating Drought Resistant Crops 4Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 2Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 3Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 4Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 5Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 6Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 7Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 8Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 9Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 10Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 11Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 12Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 13Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 2Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 3Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 4Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 5Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 6Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 7Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 8Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 9Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 10Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 11Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 12Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 13Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 14Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 15Health News:CRN Responds to 'Supplement Safety Now' Initiative 2Health News:CRN Responds to 'Supplement Safety Now' Initiative 3
... September 6, PARI,Respiratory Equipment will be f...as part of their "Breathe Easier" series. PARI is ...at provides patients, such as COPD,sufferers, with...y respiratory,diseases and those who care for them...
... overweight or obese at age 45 , , FRIDAY,...erican adults will develop osteoarthritis of the k... obese in middle age, a new study says. , A perso...ill study. People who were of normal weight at age...
...on models are enhanced by taking into account risk...ity, according to research teams led by epidemiolo...ncer Center in two complementary papers appearing ... increased exposure to certain risks. Based upon t...
...ate Medicare Advantage (MA) plans will be paid an ...pared to what the same enrollee would have cost in... according to a new report from The Commonwealth F...ke effect beginning in 2010 had been fully in pla...
...nd pancreatic tumors , , THURSDAY, Sept. 4...scoveries involving genetic mutations of two deadl...creatic cancer -- may lead to new treatments and e...p of these deadly cancers," Kenneth Kinzler, a pro...
...rtin Schiff, M.D.,is an illustrious member and rec...nd weight loss. His career is detailed in "Who,s W... Who in America," "Who,s Who in,the World," "Who,s...theories and notions concerning weight control and...
Other Medicine News:Health News:PARI Respiratory Equipment Featured on Oxygen Network 2Health News:Almost Half of Adults Will Develop Knee Osteoarthritis by 85 2Health News:Creating lung cancer risk models for specific populations refines prediction 2Health News:Creating lung cancer risk models for specific populations refines prediction 3Health News:Extra payments to Medicare Advantage plans to total $8.5 billion in 2008 2Health News:Genetic Mutations Linked to Deadly Cancers 2Health News:Genetic Mutations Linked to Deadly Cancers 3Health News:Genetic Mutations Linked to Deadly Cancers 4Health News:Phone World-famed Martin Schiff, M.D., at 310-454-6172 for Free Weight Loss 'No Diet, No Stuff' Method. Hates Diets, Loves to Have People Help Themselves 2
(Date:12/2/2009)..., , NEW YORK, Dec. 2 /PRNewswire/ -...earch report is available in its catalogue: ,, ...Markets ,, http://www.reportlinker.com/p0166...-Markets.html ,, Offer a comprehensive view of...e basis ,, Provide an overview of the major typ...
(Date:12/2/2009)..., , FRAZER, Pa., Dec. 2 /PRNewswire-...y announced that it has filed a lawsuit in U.S. Di...als USA, Inc. for infringement of U.S. Patent Nos....46 Patent") and RE37,516 (the ",516 Patent") for t...blets [C-IV]. Cephalon has a three-year period of...
(Date:12/2/2009)..., , NEW YORK, Dec. 2 /PRNewswire/ ...search report is available in its catalogue: ,,...p; Market Trends ,, http://www.reportlinker.c...nology--Market-Trends.html ,, The fast develo...tnessing a flurry of activity with pharmaceutical ...
Breaking Medicine Technology:Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 2Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 3Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 4Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 5Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 6Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 7Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 8Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 9Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 10Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 11Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 12Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals 2Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals 3Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals 4Reportlinker Adds Chiral Technology - International Technology & Market Trends 2Reportlinker Adds Chiral Technology - International Technology & Market Trends 3Reportlinker Adds Chiral Technology - International Technology & Market Trends 4Reportlinker Adds Chiral Technology - International Technology & Market Trends 5Affymetrix Reports Second Quarter 2009 Results 52465 1Affymetrix Reports Second Quarter 2009 Results 52465 2Affymetrix Reports Second Quarter 2009 Results 52465 3Affymetrix Reports Second Quarter 2009 Results 52465 4Affymetrix Reports Second Quarter 2009 Results 52465 5Affymetrix Reports Second Quarter 2009 Results 52465 6Affymetrix Reports Second Quarter 2009 Results 52465 7Affymetrix Reports Second Quarter 2009 Results 52465 8Human Genome Sciences Announces Second Quarter 2009 Financial Results and Key Developments 52463 1Human Genome Sciences Announces Second Quarter 2009 Financial Results and Key Developments 52463 2Human Genome Sciences Announces Second Quarter 2009 Financial Results and Key Developments 52463 3Human Genome Sciences Announces Second Quarter 2009 Financial Results and Key Developments 52463 4Human Genome Sciences Announces Second Quarter 2009 Financial Results and Key Developments 52463 5Human Genome Sciences Announces Second Quarter 2009 Financial Results and Key Developments 52463 6Human Genome Sciences Announces Second Quarter 2009 Financial Results and Key Developments 52463 7Human Genome Sciences Announces Second Quarter 2009 Financial Results and Key Developments 52463 8Human Genome Sciences Announces Second Quarter 2009 Financial Results and Key Developments 52463 9Human Genome Sciences Announces Second Quarter 2009 Financial Results and Key Developments 52463 10Human Genome Sciences Announces Second Quarter 2009 Financial Results and Key Developments 52463 11Human Genome Sciences Announces Second Quarter 2009 Financial Results and Key Developments 52463 12Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 1Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 2Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 3Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 4Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 5Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 6Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 7Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 8
...today reported one year,survival results from a Ph...on(R) (imexon for injection) in combination with d... or stage IV metastatic malignant,melanoma. Result...se I and,Phase II shows a 11.7 month overall mean ... overall mean survival in the subset of patients w...
...Inc., a privately-held,specialty pharmaceutical co...nical trials sponsored by its wholly owned subsidi...laRx(R) GENTAMICIN SURGICAL IMPLANT for,the preven...sing., GENTAMICIN SURGICAL IMPLANT is a fully bio...ted with the broad spectrum aminoglycoside,antibio...
Other Medicine Technology:AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma 2AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma 3AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma 4Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients 2Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients 3Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients 4
...tandard Stainless Steel. Non-Sterile Howland lock ...ble tradition of high quality standard laryngoscop...nventional blades manufactured to ISO 7673 standar...ally refined through many years of use the world o...
...tandard Chrome plated brass. Available Small/Penli...Rusch offers a reliable tradition of high quality ...with all standard/conventional blades manufactured...es have been continually refined through many year...
...usch Snap-Light™ laryngoscope blades are des...er fiber optic bundle can be removed to simplify c...unique snap-on mechanism eliminates screws that ca...rchangeable with other green coded fiber optic sys...
...reenspec Laryngoscopes are a high quality fiberopt...eater standardization to fiberoptic laryngoscopes....c and indicates it's ability to interconnect with ...light offers a cool, bright and focused light. The...
Medicine Products: